NDLI: Projecting future drug expenditures--2012.

Please wait, while we are loading the content...

Projecting future drug expenditures--2012.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Hoffman, James M. Li, Edward Doloresco, Fred Matusiak, Linda Hunkler, Robert J. Shah, Nilay D. Vermeulen, Lee C. Schumock, Glen T.
Spatial Coverage	United States
Description	Country affiliation: United States Author Affiliation: Hoffman JM ( College of Pharmacy, University of Tennessee Health Science Center, MS, Memphis, TN 38105, USA. james.hoffman@stjude.org)
Abstract	PURPOSE: Factors likely to influence drug expenditures, drug expenditure trends in 2010 and 2011, and projected drug expenditures for 2012 are discussed. SUMMARY: Data were analyzed to provide drug expenditure trends for total drug expenditures and the hospital and clinic sectors. Data were obtained from the IMS Health National Sales Perspectives database. From 2009 to 2010, total U.S. drug expenditures increased by 2.7%, with total spending rising from \$299.2 billion to \$307.5 billion. Drug expenditures in clinics grew by 6.0% from 2009 to 2010. Hospital drug expenditures increased at the moderate rate of 1.5% from 2009 to 2010; through the first nine months of 2011, hospital drug expenditures increased by only 0.3% compared with the same period in 2010. The dominant trend over the past several years is substantial moderation in expenditure growth for widely used drugs, primarily due to the ongoing introduction and wide use of generic versions of high-cost, frequently used medications. At the end of 2010, generic drugs accounted for 78% of all retail prescriptions dispensed. Another pattern is substantial increases in expenditures for specialized medications, particularly in the outpatient setting as growth in prescription drug expenditures for clinic-administered drugs consistently outpaces growth in total expenditures. Various factors are likely to influence drug expenditures in 2012, including drugs in development, the diffusion of new drugs, generic drugs, drug shortages, and biosimilars. CONCLUSION: For 2012, we project a 3-5% increase in total drug expenditures across all settings, a 5-7% increase in expenditures for clinic-administered drugs, and a 0-2% increase in hospital drug expenditures.
File Format	HTM / HTML
ISSN	10792082
Issue Number	5
Volume Number	69
e-ISSN	15352900
Journal	American Journal of Health-System Pharmacy
Language	English
Publisher	American Society of Health-System Pharmacists
Publisher Date	2012-03-01
Publisher Place	United States
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Drug Costs Economics United States Humans Discipline Pharmacy Drug Approval Health Expenditures Forecasting Ambulatory Care Journal Article Economics, Hospital Pharmaceutical Preparations Trends Drugs, Generic
Content Type	Text
Resource Type	Article
Subject	Pharmacology Pharmacy Health Policy

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Projecting future drug expenditures--2010.

Projecting future drug expenditures--2008.

Projecting future drug expenditures: 2011.

Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013.

National trends in prescription drug expenditures and projections for 2015.

FDA approves first generic enoxaparin product.

Drug price hikes and shortages have similar roots, experts say.

National trends in prescription drug expenditures and projections for 2014.

New drug and biological product approvals, 2012.

Projecting future drug expenditures--2012.

Similar Documents

Projecting future drug expenditures--2010.

Projecting future drug expenditures--2008.

Projecting future drug expenditures: 2011.

Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013.

National trends in prescription drug expenditures and projections for 2015.

FDA approves first generic enoxaparin product.

Drug price hikes and shortages have similar roots, experts say.

National trends in prescription drug expenditures and projections for 2014.

New drug and biological product approvals, 2012.

Projecting future drug expenditures--2012.